Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
| Status: | Completed |
|---|---|
| Conditions: | High Blood Pressure (Hypertension) |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/25/2018 |
| Start Date: | January 2005 |
| End Date: | January 2005 |
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
The objective of this study was to prove the bioequivalence of Ramipril 10 mg capsules under
fasting conditions.
fasting conditions.
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme
altering drugs. History of allergic or adverse response to Ramipril or any comparable
or similar product.
We found this trial at
1
site
Click here to add this to my saved trials
